For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Latest independent information about heart diseases, including medicines and non-drug treatments, written and reviewed by experts in Australia.
Heart diseases is also known as cardiovascular diseases.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience ![]() |
Date* |
|---|---|---|---|---|
An easy way to review patients at risk of cardiovascular disease |
The latest Clinical e-Audit from NPS allows GPs and GP registrars to quickly and easily target lipid-modifying therapy to those patients at increased cardiovascular disease (CVD) risk as part of a quality improvement cycle |
Media release | Others | 2011-08-16 19:00:00 |
Antipsychotic monitoring tool |
Lists recommended monitoring intervals and what you need to check for in patients taking antipsychotic medicines long term. Print (2 pages) and add this the patient's notes. |
Professional publication - NPS News | Health Professionals | 2011-08-24 00:00:00 |
Clinical audit: Safe and effective use of antipsychotic therapy |
How are you managing your patients who require antipsychotics? Review 10 patients |
Professional activity - Clinical audit | Health Professionals | 2011-08-19 00:00:00 |
Cardiovascular risk calculators |
Tools to help health professionals assess a patient’s cardiovascular risk and treatment benefit. |
Tool - Health Professional | Health Professionals | 2009-03-12 00:00:00 |
Case study 19: Dyslipidaemia and coronary heart disease risk |
Patient identified as having elevated cholesterol levels at routine health check up. He is an overweight smoker who doesn't exercise regularly. Family history of cardiovascular disease. |
Professional activity - Case study | Health Professionals | 2002-02-01 00:00:00 |
Case study 38 report: Management of ischaemic heart disease |
Patient, new to the area, presents with ischaemic heart disease. He has various cardiovascular risk factors and admits to low compliance with his medication. |
Professional activity - Case study report | Health Professionals | 2005-10-01 00:00:00 |
Case study 48 report: Achieving tight blood pressure control |
Patient diagnosed with hypertension after elevated readings over several months. Family history of cardiovascular disease. Despite adequate trial of lifestyle changes his BP remains elevated. |
Professional activity - Case study report | Health Professionals | 2007-07-01 00:00:00 |
Case study 70: Antipsychotics |
Emily (28-years-old) was diagnosed with schizophrenia 9 months ago. She was prescribed an antipsychotic (risperidone) and in the last 6 months her dose has been stable. |
Professional activity - Case study | Health Professionals | 2011-08-01 00:00:00 |
Comparative information on antipsychotics |
Lists commonly used antipsychotics and incidences of common adverse effects |
Professional publication - NPS News | Health Professionals | 2011-08-24 00:00:00 |
Antipsychotics: programs and resources for carers and consumers |
Antipsychotic treatment-related websites and phonelines to support carers or consumers |
Professional tool - Prescribing software guide | Health Professionals | 2011-08-24 00:00:00 |
Elevated cardiovascular risk with NSAIDs? |
Reviews evidence of elevated cardiovascular risk associated with COX-2 selective NSAIDs and provides guidelines for NSAID use and risk assessment. |
Professional publication - NPS RADAR - Review | Health Professionals | 2005-08-01 00:00:00 |
Clinical audit: Safe and effective use of antipsychotic therapy |
How are you managing your patients who require antipsychotics? Review 10 patients |
Professional activity - Clinical audit | Health Professionals | 2011-08-19 00:00:00 |
Find out your risk score before it’s game over |
Australians should pay as much attention to their heart and stroke risk score as the footy score this autumn, according to NPS MedicineWise, which has launched a new campaign focusing on cardiovascular disease |
Media release | Others | 2011-04-11 19:00:00 |
Fish oil supplements and cardiovascular disease |
Fish oil supplements may be useful for people who cannot meet the dietary recommendations for fish intake, or for people with hypertriglyceridaemia. For people receiving standard treatment for cardiovascular disease, the benefit of a fish oil supplement appears modest. Read more. |
Professional publication - NPS factsheet | Health Professionals | 2011-08-19 00:00:00 |
Hypertension management |
Reviews hypertension management to reduce cardiovascular risk by lifestyle changes and prescribing of thiazides and herbal medicines, a focus on reducing risk in diabetics |
Professional publication - NPS News | Health Professionals | 2003-08-01 00:00:00 |
Type 2 diabetes - Reducing risk in |
Ways to prevent cardiovascular disease by preventing and managing type 2 diabetes with lifestyle changes and treatment focused on metformin and insulin management. |
Professional publication - NPS News | Health Professionals | 2005-04-01 00:00:00 |
Antipsychotics - balancing benefits and harms |
This NPS News discusses ways to achieve the most favourable balance of clinical benefits and adverse effects for people with a psychotic illness or behavioural symptoms of dementia. |
Professional publication - NPS News | Health Professionals | 2011-08-01 00:00:00 |
NPS Prescribing Practice Review 24: Using antithrombotics: maximising benefits; minimising risks |
Information on the use of antiplatelet drugs (e.g. aspirin) to prevent cardiovascular events. Use of warfarin to prevent thromboembolism in atrial fibrillation is also discussed. |
Professional publication - Prescribing Practice Review | Health Professionals | 2003-11-10 00:00:00 |
Antipsychotic therapy - benefits and harms |
Reviews ways to achieve the best balance of clinical benefits and adverse effects for those with a psychotic illness or behavioural symptoms of dementia |
Professional publication - Prescribing Practice Review | Health Professionals | 2011-08-25 00:00:00 |
Ramipril (Tritace) titration pack |
Reviews use of ramipril titration pack for cardiovascular risk reduction, with emphasis on efficient use of tablets for dose titration to 10 mg daily. |
Professional publication - NPS RADAR - Review | Health Professionals | 2003-11-01 00:00:00 |
Use of CV risk assessments must increase to combat rise in cardiovascular disease |
Cardiovascular disease is the single largest cause of death in Australia. It affects 1 in 6 people – a figure expected to increase to 1 in 4 by 2050. More than half of Australians aged over 25 have cholesterol levels considered to be high. |
Media release | Others | 2011-02-02 19:00:00 |
Who is at risk of type 2 diabetes? - Independent medicine & health information |
Risk factors for diabetes can include a combination of high glucose levels, age over 40 years, family history, overweight/obese, high blood pressure, cardiovascular disease & a history of gestational diabetes. Also at risk are people of Aboriginal, Torres Strait Island, Pacific Island, Indian & Chinese origin, & women with polycystic ovary syndrome. Read more. |
Web page | Consumers,Others,Research & Evaluation community | 2011-11-14 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.